Information  X 
Enter a valid email address

Company Name matching 'Orion Oyj'

Date
Time Source
Company
Announcement
25 Nov 2021 8:30 am GNW   Orion Oyj Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2022 Annual General Meeting
11 Nov 2021 8:30 am GNW   Orion Oyj Orion Research Foundation grants 991,910 euros for research in 2022
20 Oct 2021 10:00 am GNW   Orion Oyj Orion Group Interim Report 1–9/2021
08 Oct 2021 4:30 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
  7:00 am GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
05 Oct 2021 7:00 am GNW   Orion Oyj Orion publishes Interim Report for January–September 2021 on Wednesday 20 October 2021
17 Sep 2021 7:00 am GNW   Orion Oyj Successor plan of the President and CEO of Orion
14 Sep 2021 7:00 am GNW   Orion Oyj 90,889 Orion Corporation A shares converted into B shares
18 Aug 2021 7:00 am GNW   Orion Oyj Orion Corporation and Alligator Bioscience announce immuno-oncology research collaboration and license agreement
17 Aug 2021 6:00 am GNW   Orion Oyj Orion will remain as the owner of pharmaceutical manufacturing plant in Kuopio, Finland
03 Aug 2021 12:00 pm GNW   Orion Oyj Orion Corporation signs European wide marketing and distribution agreement with Marinus Pharmaceuticals for ganaxolone
22 Jul 2021 1:00 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
21 Jul 2021 1:45 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
19 Jul 2021 10:00 am GNW   Orion Oyj Orion Group Half-Year Financial Report 1-6/2021
  9:00 am GNW   Orion Oyj Orion Corporation's financial reporting and Annual General Meeting in 2022 
16 Jul 2021 1:30 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
15 Jul 2021 2:00 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
12 Jul 2021 6:00 am GNW   Orion Oyj Orion recalls Multivita Forte dietary supplement from consumers
08 Jul 2021 7:00 am GNW   Orion Oyj 32,884 Orion Corporation A shares converted into B shares
02 Jul 2021 1:00 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
  11:40 am GNW   Orion Oyj Orion publishes Half-Year Financial Report for January–June 2021 on Monday 19 July 2021
30 Jun 2021 1:35 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
29 Jun 2021 2:46 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
28 Jun 2021 6:45 am GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
23 Jun 2021 1:30 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
  6:00 am GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
21 Jun 2021 7:30 am GNW   Orion Oyj Orion Animal Health’s Tessie® (tasipimidine) receives positive CVMP opinion
18 Jun 2021 12:40 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
17 Jun 2021 1:40 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
09 Jun 2021 10:00 am GNW   Orion Oyj Orion’s Clinical Trial Shows Significant Improvement for Chronic Pain Patients Using Virtual Reality Therapy
08 Jun 2021 6:00 am GNW   Orion Oyj Orion and the Blood Service launch collaboration to develop new CAR T-cell cancer therapy
28 May 2021 1:45 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
27 May 2021 4:50 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
26 May 2021 8:15 am GNW   Orion Oyj Orion’s Virtual Capital Markets Day today at 13.00 EEST – presentation material now available
25 May 2021 7:50 am GNW   Orion Oyj Orion to investigate possible sale of its pharmaceutical manufacturing plant in Kuopio, Finland
20 May 2021 5:15 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
19 May 2021 1:00 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
17 May 2021 2:00 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
  1:00 pm GNW   Orion Oyj Orion Animal Health’s Bonqat® (pregabalin) receives positive CVMP opinion
11 May 2021 2:30 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
05 May 2021 12:00 pm GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
  10:15 am GNW   Orion Oyj Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
04 May 2021 7:00 am GNW   Orion Oyj Invitation to Orion’s Virtual Capital Markets Day on 26 May 2021
27 Apr 2021 5:50 pm GNW   Orion Oyj CORRECTION: Composition of the Nomination Committee of Orion Corporation
  4:20 pm GNW   Orion Oyj Composition of the Nomination Committee of Orion Corporation
  10:00 am GNW   Orion Oyj Orion Group Interim Report 1-3/2021
  7:00 am GNW   Orion Oyj Orion aims to achieve carbon neutrality by 2030
12 Apr 2021 10:00 am GNW   Orion Oyj Orion publishes Interim Report for January–March 2021 on Tuesday 27 April 2021
25 Mar 2021 3:55 pm GNW   Orion Oyj Orion Corporation: Organising meeting of the Board of Directors
  1:35 pm GNW   Orion Oyj Decisions taken by Orion Corporation’s Annual General Meeting on 25 March 2021
15 Mar 2021 11:00 am GNW   Orion Oyj Save the date – Orion’s Virtual Capital Markets Day on 26 May 2021 at 1.00 p.m. – 4.00 p.m. EEST
03 Mar 2021 9:30 am GNW   Orion Oyj Change to the Notice of Orion Corporation’s Annual General Meeting
02 Mar 2021 9:45 am GNW   Orion Oyj Orion Group Financial Statement documents 2020, Corporate Governance Statement and Remuneration Report published
01 Mar 2021 4:45 pm GNW   Orion Oyj Orion Corporation: Transfer of 99,768 own B shares on 1 March 2021
09 Feb 2021 10:15 am GNW   Orion Oyj Notice to the Annual General Meeting of Orion Corporation
  10:00 am GNW   Orion Oyj Orion Group Financial Statement Release for 2020
08 Feb 2021 12:00 pm GNW   Orion Oyj Orion and Bayer expand development program for darolutamide in prostate cancer
02 Feb 2021 6:30 am GNW   Orion Oyj 83,386 Orion Corporation A shares converted into B shares
20 Jan 2021 9:00 am GNW   Orion Oyj Orion publishes Financial Statement Release for 2020 on Tuesday 9 February 2021
18 Jan 2021 7:00 am GNW   Orion Oyj Orion Animal Health and Vetoquinol expand collaboration – Vetoquinol to distribute Orion’s Clevor® in the USA and Orion to distribute Drontal® and Profender® products in Finland, Hungary and Romania


Company Announcements Archive »


a d v e r t i s e m e n t